N-{3-[(5-Cyclopropyl-2-{[4-(4-morpholinyl)phenyl]amino}-4-pyrimidinyl)amino]propyl}cyclobutanecarboxamide

Request For Quotation
N-{3-[(5-Cyclopropyl-2-{[4-(4-morpholinyl)phenyl]amino}-4-pyrimidinyl)amino]propyl}cyclobutanecarboxamide Suppliers list
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: Shanghai meikai technology co., ltd  
Tel: 021-68689288 15300790979
Email: info@mkbio.com.cn
Company Name: TargetMol Chemicals Inc.  
Tel: 13564774135
Email: marketing@targetmol.com

N-{3-[(5-Cyclopropyl-2-{[4-(4-morpholinyl)phenyl]amino}-4-pyrimidinyl)amino]propyl}cyclobutanecarboxamide manufacturers

  • MRT-68601 HCl
  • MRT-68601 HCl pictures
  • $1980.00
  • 2026-05-11
  • CAS:1190379-37-3
  • Purity:
  • Supply Ability: 10g
N-{3-[(5-Cyclopropyl-2-{[4-(4-morpholinyl)phenyl]amino}-4-pyrimidinyl)amino]propyl}cyclobutanecarboxamide Basic information
Product Name:N-{3-[(5-Cyclopropyl-2-{[4-(4-morpholinyl)phenyl]amino}-4-pyrimidinyl)amino]propyl}cyclobutanecarboxamide
Synonyms:N-{3-[(5-Cyclopropyl-2-{[4-(4-morpholinyl)phenyl]amino}-4-pyrimidinyl)amino]propyl}cyclobutanecarboxamide;MRT-68601;Cyclobutanecarboxamide, N-[3-[[5-cyclopropyl-2-[[4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]amino]propyl]-;MRT 68601 HCl;MRT68601 HCl;MRT-68601 HCl;MRT 68601 HCl,MRT68601 HCl
CAS:1190379-37-3
MF:C25H34N6O2
MW:450.58
EINECS:
Product Categories:
Mol File:1190379-37-3.mol
N-{3-[(5-Cyclopropyl-2-{[4-(4-morpholinyl)phenyl]amino}-4-pyrimidinyl)amino]propyl}cyclobutanecarboxamide Structure
N-{3-[(5-Cyclopropyl-2-{[4-(4-morpholinyl)phenyl]amino}-4-pyrimidinyl)amino]propyl}cyclobutanecarboxamide Chemical Properties
Safety Information
MSDS Information
N-{3-[(5-Cyclopropyl-2-{[4-(4-morpholinyl)phenyl]amino}-4-pyrimidinyl)amino]propyl}cyclobutanecarboxamide Usage And Synthesis
DescriptionMRT-68601 HCl is a potent TBK1 (TANK-binding kinase-1). It inhibits the formation of autophagosomes in lung cancer cells.
UsesMRT 68601 is a potent TBK1 inhibitor with the activity of inhibiting autophagosome formation in lung cancer cells. MRT 68601 may have potential effects against targets associated with host-dependent factors identified in SARS-CoV-2 infection. The drug targets involved in MRT 68601 are related to existing FDA-approved drugs and compounds in clinical trials, which can provide support for the development of broad-spectrum antiviral therapies[1].
References[1] A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing DOI:10.1101/2020.03.22.002386
N-{3-[(5-Cyclopropyl-2-{[4-(4-morpholinyl)phenyl]amino}-4-pyrimidinyl)amino]propyl}cyclobutanecarboxamide Preparation Products And Raw materials
Tag:N-{3-[(5-Cyclopropyl-2-{[4-(4-morpholinyl)phenyl]amino}-4-pyrimidinyl)amino]propyl}cyclobutanecarboxamide(1190379-37-3) Related Product Information
Doxorubicin hydrochloride Olaparib Ruxolitinib Rapamycin Metformin Brefeldin A